Study finds inadequate FDA oversight of prescribing of fentanyl products

(Johns Hopkins University Bloomberg School of Public Health) A study led by researchers at the Johns Hopkins Bloomberg School of Public Health suggests that the Food and Drug Administration (FDA) and manufacturers did not take action when evidence emerged that potentially lethal fentanyl products were being inappropriately prescribed to patients.

from EurekAlert! - Social and Behavioral Science http://bit.ly/2tqBc9y